scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1039285893 |
P356 | DOI | 10.1038/ONC.2012.538 |
P698 | PubMed publication ID | 23178489 |
P5875 | ResearchGate publication ID | 233768526 |
P50 | author | Robert C Baxter | Q41789383 |
Kamila A Marzec | Q85235584 | ||
P2093 | author name string | J L Martin | |
M Z Lin | |||
P2860 | cites work | EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment | Q24338426 |
Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells | Q28139221 | ||
Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit | Q28144419 | ||
Chromosomal stability and the DNA double-stranded break connection | Q28205315 | ||
Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization | Q28212205 | ||
Cellular actions of the insulin-like growth factor binding proteins | Q28216659 | ||
Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase | Q40401323 | ||
Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks. | Q40464510 | ||
Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae | Q40531770 | ||
Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling. | Q40568878 | ||
Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases | Q40689818 | ||
Regulated migration of epidermal growth factor receptor from caveolae | Q40923075 | ||
Insulin-Like Growth Factor Binding Protein Secretion by Breast Carcinoma Cell Lines: Correlation with Estrogen Receptor Status* | Q41713966 | ||
Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer | Q42439833 | ||
IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity | Q43183473 | ||
Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulation | Q44405114 | ||
F-actin-dependent insolubility of chromatin-modifying components | Q44843426 | ||
Insulin-like growth factor binding protein 3 modulates epidermal growth factor (EGF)-induced growth of breast epithelial cells by altering EGF receptor internalization | Q46942900 | ||
Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells | Q47859644 | ||
Circulating binding proteins for the insulinlike growth factors | Q47874668 | ||
IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC) | Q56336664 | ||
Gene expression correlates of clinical prostate cancer behavior | Q60156349 | ||
Lipid Rafts: Membrane Triage Centers | Q61040919 | ||
Correlation of Insulin-Like Growth Factor-Binding Protein-3 Messenger RNA With Protein Expression in Primary Breast Cancer Tissues: Detection of Higher Levels in Tumors With Poor Prognostic Features | Q62267737 | ||
Association of insulin-like growth factor binding protein-3 expression with melanoma progression | Q79436245 | ||
Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma | Q80190770 | ||
Analysis of the cellular uptake and nuclear delivery of insulin-like growth factor binding protein-3 in human osteosarcoma cells | Q28236310 | ||
Cancer-susceptibility genes. Gatekeepers and caretakers | Q28236512 | ||
Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity | Q28253045 | ||
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis | Q28258638 | ||
IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments | Q28270043 | ||
Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma | Q28274499 | ||
The DNA-dependent protein kinase | Q28373950 | ||
Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib | Q30425201 | ||
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034. | Q33407127 | ||
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma | Q33747609 | ||
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data | Q33779753 | ||
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics | Q33801855 | ||
DNA double strand break repair and chromosomal translocation: lessons from animal models | Q34405417 | ||
High-resolution FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell plasma membranes | Q34709520 | ||
Nuclear export and mitochondrial and endoplasmic reticulum localization of IGF-binding protein 3 regulate its apoptotic properties | Q35215665 | ||
Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis | Q35872734 | ||
Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer | Q36138971 | ||
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer | Q36614337 | ||
Lipid rafts and membrane traffic | Q36768730 | ||
Is NHEJ a tumor suppressor or an aging suppressor? | Q37140392 | ||
Trafficking of receptor tyrosine kinases to the nucleus | Q37308472 | ||
Tumor suppression by ARF: gatekeeper and caretaker | Q37656961 | ||
Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function | Q37676970 | ||
Breast cancer statistics, 2011. | Q37942073 | ||
Links between genome integrity and BRCA1 tumor suppression. | Q38029897 | ||
Accurate in vitro end joining of a DNA double strand break with partially cohesive 3'-overhangs and 3'-phosphoglycolate termini: effect of Ku on repair fidelity | Q38301821 | ||
BRCA1-dependent Chk1 phosphorylation triggers partial chromatin disassociation of phosphorylated Chk1 and facilitates S-phase cell cycle arrest | Q39323364 | ||
A requirement for polymerized actin in DNA double-strand break repair | Q39333046 | ||
Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1. | Q39416078 | ||
DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining | Q39543261 | ||
IGFBP-3 Can Either Inhibit or Enhance EGF-mediated Growth of Breast Epithelial Cells Dependent upon the Presence of Fibronectin | Q39654146 | ||
Effects of endogenous insulin-like growth factor binding protein-3 on cell cycle regulation in breast cancer cells. | Q39773767 | ||
Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. | Q39940485 | ||
Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. | Q40172994 | ||
Phosphorylation by DNA-dependent protein kinase is critical for apoptosis induction by insulin-like growth factor binding protein-3. | Q40208048 | ||
Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis. | Q40304159 | ||
Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment | Q40310878 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | breast cancer | Q128581 |
preproinsulin | Q7240673 | ||
P304 | page(s) | 85-96 | |
P577 | publication date | 2012-11-26 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents | |
P478 | volume | 33 |
Q92282336 | Altered blood proteome in girls with high urine concentrations of bisphenol a, genistein, mono-ethyl hexylphthalate and mono-benzyl phthalate |
Q92901911 | Blocking transmembrane219 protein signaling inhibits autophagy and restores normal cell death |
Q35236778 | Differences in IGF-axis protein expression and survival among multiethnic breast cancer patients |
Q35123145 | Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes |
Q89861903 | Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma |
Q33866151 | Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer. |
Q38893600 | Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer. |
Q28237971 | IGF binding proteins in cancer: mechanistic and clinical insights |
Q64387949 | IGFBP-3 interacts with NONO and SFPQ in PARP-dependent DNA damage repair in triple-negative breast cancer |
Q38640378 | Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade. |
Q38688202 | Insider trading: Extracellular matrix proteins and their non-canonical intracellular roles |
Q38641329 | Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies |
Q36433403 | Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01) |
Q37004744 | Insulin-like growth factor binding protein-3 (IGFBP-3): Novel ligands mediate unexpected functions |
Q37688258 | Insulin-like growth factor binding protein-3 links obesity and breast cancer progression. |
Q36413546 | Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage |
Q42600588 | Involvement of the insulin-like growth factor binding proteins in the cancer cell response to DNA damage |
Q54117329 | Nuclear Insulin-Like Growth Factor Binding Protein-3 As a Biomarker in Triple-Negative Breast Cancer Xenograft Tumors: Effect of Targeted Therapy and Comparison With Chemotherapy. |
Q28080513 | Nuclear actions of insulin-like growth factor binding protein-3 |
Q92729642 | Paracrine senescence of human endometrial mesenchymal stem cells: a role for the insulin-like growth factor binding protein 3 |
Q42364417 | Profiling of gene expression regulated by 17β-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines |
Q97546454 | RNA-binding proteins in tumor progression |
Q47435335 | Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells |
Q26801886 | Targeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast Cancer |
Q92642332 | Therapeutic Targeting of the IGF Axis |
Q26798408 | Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment |
Search more.